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Abstract: The aim of this study was to determine the anti-inflammatory potential of pomegranate
peel extracts (PPE) prepared from waste material of pomegranate juice production both in vitro
on Caco-2 cells and ex vivo using porcine colonic tissue explants. Caco-2 cells were stimulated
in vitro by TNF and colonic tissue explants were stimulated ex vivo with lipopolysaccharide (LPS).
Both tissues were co-treated with PPE at 0, 1.0, 2.5, 5.0, 10 and 25 µg/mL. The secretion of CXCL8
in the supernatant of both experiments was determined by enzyme linked immunosorbent assay
(ELISA) and the relative expression of inflammatory cytokines were evaluated in the colonic tissue
by quantitative polymerase chain reaction (QPCR). The 2.5 to 25 µg/mL of PPE suppressed CXCL8
(p < 0.001) in the Caco-2 cells, whereas CXCL8 production was suppressed by only 5 and 25 µg/mL
(p < 0.01) of PPE in the colonic explants. The 5 µg/mL of PPE also suppressed the expression of IL1A
(p < 0.05), IL6 (p < 0.01) and CXCL8 (p < 0.05) in LPS challenged colonic tissues compared to controls.
In conclusion, the 5 µg/mL of PPE consistently elicits strong anti-inflammatory activity. These results
support the potential of bioactive compounds from the waste peel of pomegranate in terms of their
anti-inflammatory activity in cells and tissues of the gastrointestinal tract.
Keywords: anti-inflammatory effects; human colonic adenocarcinoma cells (Caco-2 cells); porcine
colonic tissues; pomegranate (Punica granatum L.) peel extracts; polyphenols; punicalagin;
circular economy
1. Introduction
Epidemiological studies have identified an inverse relationship between the incidence of a range
of common non-communicable diseases and the consumption of fruits and vegetables that contain
valuable bioactive compounds; a relationship that is consistent with the principles of the Mediterranean
diet [1–4]. Foods rich in polyphenols have attracted interest due to their beneficial effects on human
health, with evidence of antioxidant [5,6], anti-cancer [7–10], cardio-protective and anti-inflammatory
activities [11–13]. Fruits are used commonly for juice or pulp extraction, a process which generates large
amounts of waste containing valuable bioactive compounds [14,15]. The recovery of these bioactive
molecules and their reuse within agricultural, food, cosmetic and pharmaceutical industries supports
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the core principles of the “circular economy” [16]. This recently conceived economic model is based on
sustainable processes at “zero waste” that we have already described in previous studies [17–19].
Punica granatum L., commonly known as pomegranate, is consumed worldwide as either fresh
fruit or in the form of juice and is recognised for its antioxidant, antimicrobial, anti-inflammatory and
anti-cancer health benefits [20–23]. Originally native to Iran, over time the fruit has gained increased
popularity and are now produced in a number of countries including Tunisia, Turkey, Spain, Italy,
Egypt, Morocco, United States, China, India, Argentina, Israel and the South Africa. The variety
“Wonderful” is the most widely cultivated due to its high yield and quality [24]. The fruit consists of
three main parts: the arils, the seeds and the peel, each contributing 40%, 10% and 50% of the total
fruit weight, respectively. The arils contain discrete quantities of flavonoids, principally anthocyanins,
which are responsible for the red colour of the juice. The seeds and seed oil contain high levels of
polyunsaturated fatty acids. The peel, the main waste component of pomegranate juice production, is
particularly rich of hydrolysable tannins, specifically punicalagins, which are multiple esters of gallic
acid and glucose, widely known for their antioxidant and anti-inflammatory properties [25–31].
Several disorders related to the chronic inflammation of the gastrointestinal tract (GIT), including
ulcerative colitis and Crohn’s disease are classified broadly as Inflammatory Bowel Disease (IBD) [32].
A range of genetic, immunological and environmental factors are thought to be responsible for the
development of IBD and its incidence is increasing throughout the world [33]. Numerous studies have
illustrated the imbalance of cytokines during acute and chronic inflammation and their role in the
modulation of the immune response and resolution of inflammation. Un-regulated immune activation
in the GIT drives chronic inflammation and disease [34]. Hence, immunomodulatory supplements that
support GIT health are constantly being sought and polyphenols found in plant-based foods could be
effective in this regard [35–37].
In this study, the anti-inflammatory effects of standardised pomegranate peel extracts (PPE)
were investigated using an in vitro model where human colonic adenocarcinoma Caco-2 cells were
stimulated with TNF and an ex vivo model using porcine colonic tissues stimulated with LPS.
The effects were studied using non-cytotoxic concentrations of PPE on Caco-2 cell lines (1.0, 2.5,
5.0, 10 and 25 µg/mL). Caco-2 cells represent the epithelial layer of the small intestine, they have
a functional resemblance to the colonic enterocytes and an ability to respond to pro-inflammatory
stimuli; hence this in vitro system is a useful model of the human intestine with regard to screening
potential bioactive compounds [37,38]. One caveat however, is that this in vitro model lacks the cellular
heterogeneity present in the colon in vivo [39]; hence, to circumvent this limitation, ex vivo intestinal
tissues explants were used as a validation model as they are informative with regard to physiological
and immunological responses both under normal and challenged conditions [39,40]. The total RNA in
porcine colonic explants remains intact for up to 3 h post-mortem, hence this ex vivo system can be
used to explore and validate the effects of bioactive compounds on the transcriptome in the presence
or absence of inflammatory stimulants [41].
The objective of this current study was to evaluate the anti-inflammatory effects of incremental
PPE concentrations (1.0, 2.5, 5.0, 10 and 25 µg/mL) on an in vitro model using Caco-2 cells stimulated
with TNF and ex vivo model using porcine colonic tissues stimulated with LPS. To the best of our
knowledge, this paper describes for the first time the anti-inflammatory effects of PPE in an ex vivo
porcine colonic model.
2. Materials and Methods
2.1. Plant Material, Extraction Procedure and Chemical Characterisation
Punica granatum L. (“Wonderful” variety) fruits were collected in Grosseto (Tuscany, Italy; Latitude:
42◦45′46′′ N; Longitude: 11◦06′33′′ E). The pomegranate peel extract (PPE) was prepared as already
described [42–44]. Briefly, the crushed peel was treated with ultrapure water (weight/volume = 1/12)
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at 100 ◦C, the residue was filtered and water removed by lyophilisation using LYOVAC GT 2 (Leybold
AJ-Cologne, Germany).
High Performance Liquid Chromatography (HPLC)/Diode Array Detection (DAD)/Electron Spray
Ionisation (ESI)-Mass Spectrometry (MS) analyses were carried out using a HP-1100 liquid chromatograph
equipped with a DAD detector, a HP 1100 MSD API-electrospray (Agilent Technologies-Palo Alto, CA,
USA) detector, a Luna C18 column 250 × 4.60 mm, 5 µm (Phenomenex-Torrance, CA, USA) using
the analytical conditions already described [44]. The Nuclear Magnetic Resonance (NMR) spectra were
recorded using a 400 MHz nuclear magnetic resonance spectrometer Advance III (Bruker, Germany) [42,43].
2.2. Caco-2 Cell Culture
Caco-2 cells were supplied by the American Type Culture Collection (ATCC) and maintained in
75 cm2 cell culture flasks and Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen, San Diego,
CA, USA) supplemented with 10% (v/v) fetal bovine serum (Invitrogen Corp.), 1.0% sodium pyruvate,
1.0% non-essential amino acids and 1.0% penicillin-streptomycin (Sigma-Aldrich, St. Louis, MO, USA)
at 37 ◦C in a humidified 5% CO2 incubator.
2.2.1. Cytotoxicity Evaluation
To evaluate the cytotoxic activity of PPE, the cells were plated into 96-well microplates at
1 × 106 cells/mL and maintained for 21 days until fully differentiated. After that, the media was
replaced with different concentrations of PPE (1.0, 2.5, 5.0, 10, 25 µg/mL) and one aliquot of cells
was treated with regular medium (control). The cell culture plates were incubated at 37 ◦C for 24 h.
Cell viability was measured at the end of the exposure time, using an MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) assay, in the following way: all treatments were replaced with
100 µL of MTT solution (regular medium and MTT) to 0.5 mg/mL of final concentration and the plates
were kept again in incubator for 3.5 h; after incubation, the supernatants were discarded and 100 µL of
dimethyl sulfoxide (DMSO) were added to each well; plates were additionally incubated for 45 min
and subsequently read at 595 nm by microplates reader, absorbance data were recorded.
2.2.2. In Vitro Interleukin 8 (CXCL8) Detection using Enzyme Linked Immunosorbent Assay (ELISA)
For CXCL8 detection from Caco-2 cells, the cells were plated in a 24 well plate at 106 cells mL−1
of density and maintained for 21 days until fully differentiated. The media was changed on alternative
days. The cells used in this study were between the 53rd to 65th passages. After 21 days, an aliquot
of cells was treated with DMEM and 10 nM Dexamethasone (Dexa) (Sigma-Aldrich) a commercially
available anti-inflammatory agent; another aliquot was treated with only DMEM (Control); the other
cells were treated with DMEM containing increasing concentrations of PPE (1.0, 2.5, 5.0, 10, 25 µg/mL).
All treatments contained 10 nM TNF (Sigma-Aldrich) with the aim of inducing a pro-inflammatory
response. After 24 h of treatment, supernatants were removed and CXCL8 concentrations were
measured using the Human CXCL8 ELISA kit (R&D Systems Europe, Ltd. Abingdon, UK).
2.3. Ex Vivo Porcine Colonic Tissue Collection and Treatment
Six 38 day-old pigs were sacrificed and colonic tissues were dissected and washed using phosphate
buffer saline (PBS). From each colonic tissue, sections of about 1.0 cm2 of tissue were taken and the
smooth muscle was stripped from the overlying epithelium and discarded. For each animal, one
section was immediately placed in 15 mL of RNAlater® (Applied Biosystems, Foster City, CA, USA) as
time-zero control (T0) and stored at room temperature. Another tissue section was incubated in DMEM
(Control) and further tissue sections were incubated in different wells, each one containing DMEM
with increasing concentrations of PPE (1.0, 2.5, 5.0, 10, and 25 µg/mL). To induce an inflammatory
response, each treatment, with the only exception of T0, contained 10 µg/mL of LPS (Sigma Aldrich).
All tissue explants were incubated at 37 ◦C for 3 h and following this, the supernatants were stored at
Nutrients 2019, 11, 548 4 of 15
−20 ◦C, surplus media was removed from the tissue and the tissue was stored in 15 mL of RNAlater®
overnight at room temperature. The RNAlater® was then removed and the samples stored at −80 ◦C.
2.3.1. Ex Vivo Interleukin 8 (CXCL8) Detection using ELISA
The CXCL8 concentrations were measured in the supernatants collected 3 h post LPS stimulation
of the colonic explants using the Porcine CXCL8 ELISA kit (R&D Systems Europe, Ltd. Abingdon, UK).
2.3.2. RNA Extraction and cDNA Synthesis
Total RNA was extracted from colonic tissues using Trizol (Sigma-Aldrich) with a further
purification using GenElute™ Mammalian Total RNA Miniprep Kit (Sigma-Aldrich), according to
the manufacturer’s instructions. During the process, genomic DNA was removed using DNAse I
(Sigma-Aldrich). Total RNA was quantified using a NanoDrop-ND1000 Spectrophotometer (Thermo
Fisher Scientific Inc., Waltham, MA, USA). The cDNA was synthesised using First Strand cDNA
Synthesis Kit (Qiagen Ltd. Crawley, UK), 1.0 µg of total RNA and oligo dT primers, in accordance
with the manufacturer’s instructions. The final volume of cDNA was adjusted to 250 µL with nuclease
free water.
2.3.3. Quantitative Real-Time PCR (QPCR)
The relative expression of a panel of nine cytokines were evaluated using QPCR: interleukin
1 alpha (IL1A), interleukin 1 beta (IL1B), interleukin 6 (IL6), interleukin 8 (CXCL8), interleukin 10
(IL10), interleukin 17A (IL17A), interferon gamma (IFNG), Tumor Necrosis Factor alpha (TNF) and
Transforming Growth Factor beta 1 (TGFB1). Two endogenous controls, β2 microglobulin (B2M) and
Beta-actin (ACTB) were used to normalize data [39]. Primers used for these targets are described in
Table 1. Primer efficiencies were determined using a serial dilution (1:4 dilution series over 7 points) of
a cDNA pool from all the experimental samples and were in the range of 90 to 110%. All primers were
designed using Primer Express™ software and were synthesised by MWG Biotech (Milton Keynes, UK).
Assays were carried out using 96 well fast optical plates on a 7500HT ABI Prism Sequence Detection
System (PE Applied Biosystems, Foster City, CA, USA) using Fast SYBR Green PCR Master Mix
(Applied Biosystems). All reactions were performed in duplicate to a final volume of 20 µL containing
10 µL Fast SYBR PCR Master mix, 1 µL forward and reverse primer mix (100 µM), 8 µL nuclease free
water and 1 µL of cDNA. The thermal cycling conditions were 95 ◦C for 10 min followed by 40 cycles
of 95 ◦C for 15 s and 65 ◦C for 1 min followed by a dissociation curve analysis to confirm specificity.
The stability of the reference genes and normalisation factors (NF) were calculated using the qbase+
package (Biogazelle, Gent, Belgium) based on the geNorm algorithm. Briefly, geNorm calculated the
stability measure M for a reference gene as the average pairwise variation (V) for that gene with all
other tested reference genes. A Vn/n+1 value was calculated for every comparison between two
consecutive numbers (n and n+1) of candidate reference genes. Following the stepwise exclusion of
the least stable reference genes, M values were re-calculated and the stability series obtained. Finally,
the normalisation factor was calculated from the two most stable genes (B2M, ACTB), as the geometric
mean of the most stable reference genes, and the normalised relative quantity (RQ) of the target genes
is obtained which is an expression of the ratio between the RQ and the sample specific NF. The basic
formula for relative quantification (RQ = 2ˆddCt) assumes 100% amplification efficiency (E = 2).
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Table 1. Oligonucleotide sequences of forward and reverse primers used in QPCR.
Accession Number Forward Primer (5′–3′) Tm (◦C) Reverse Primer (5′–3′) Tm (◦C) Product Length (bp) Efficiency (%)
Reference gene
ACTB XM_001928093.1 GCACGGCATCATCACCAA 52.75 CCGGAGCTCGTTGTAGAAGGT 55.99 70 95.02
B2M NM_213978.1 CGGAAAGCCAAATTACCTGAAC 62.10 TCTCCCCGTTTTTCAGCAAA 62.20 83 103.8
Cytokine gene
IL1A NM_214029.1 CAGCCAACGGGAAGATTCTG 63.0 ATGGCTTCCAGGTCGTCAT 60.49 76 106.6
IL1B NM_001005149.1 TTGAATTCGAGTCTGCCCTGT 60.59 CCCAGGAAGACGGGCTTT 60.94 76 104
IL6 AB194100 AGACAAAGCCACCACCCCTAA 55.27 CTCGTTCTGTGACTGCAGCTTATC 59.92 69 99.99
CXCL8 NM_213867.1 TGCACTTACTCTTGCCAGAACTG 61.9 CAAACTGGCTGTTGCCTTCTT 61.7 82 95.7
IL10 NM_214041.1 GCCTTCGGCCCAGTGAA 63.4 AGAGACCCGGTCAGCAACAA 63.1 71 95.7
IL17A NM_001005729.1 CCCTGTCACTGCTGCTTCTG 60.57 TCATGATTCCCGCCTTCAC 60.40 57 101.2
IFNG NM_213948.1 TCTAACCTAAGAAAGCGGAAGAGAA 61.12 TTGCAGGCAGGATGACAATTA 61.54 81 94.4
TNF NM_214022.1 TGGCCCCTTGAGCATCA 62.5 CGGGCTTATCTGAGGTTTGAGA 62.8 68 91.5
TGFB1 NM_214015.1 AGGGCTACCATGCCAATTTCT 60.63 CGGGTTGTGCTGGTTGTACA 61.68 101 93
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2.4. Statistical Analysis
All data were normalised and analysed as a complete randomised design experiment using
one way ANOVA function of GraphPad PRISM software. Spearman’s rank correlation analysis was
performed to correlate the expression of the selected panel of cytokine expression post LPS challenge.
Probability values of p <0.05 were used as the criterion for statistical significance. All results are
reported as square means ± standard error of the means.
3. Results
3.1. Polyphenolic Composition of PPE
The polyphenol composition of PPE is presented in Figure 1. Both high-molecular and low-molecular
weight phenolic compounds are present. High-molecular weight phenols were α- and β-punicalagin with
146.9 ± 1.465 mg/g and 266.3 ± 1.687 mg/g, respectively; gallic acid, ellagic acid and granatin B were
low-molecular weight phenols found into PPE as minor components, as published previously [42,43].
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analysis was carried out using a HP-1100 liquid chromatograph equipped with a Diode Array 
Detection (DAD) detector, a HP 1100 MSD API-electrospray (Agilent Technologies) detector and a 
Luna C18 column 250 × 4.60 mm. The NMR spectra were recorded using a 400 MHz nuclear magnetic 
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3.2. Experimental Results on Caco-2 cells 
3.2.1. Cytotoxicity on Caco-2 cells 
The cytotoxic effects of PPE on Caco-2 cells are presented in Figure 2. No cytotoxic effects were 
observed in Caco-2 cells treated for 24 h with PPE at any concentrations tested 1.0, 2.5, 5.0, 10 and 25 
μg/mL (p > 0.05). 
Figure 1. Phenolic compounds found in Pomegranate Peel Extracts (PPE) using High Performance
Liquid Chromatography (HPLC) and Nuclear Magnetic Resonance (NMR) analyses. The HPLC
analysis was carried out using a HP-1100 liquid chromatograph equipped with a Diode Array Detection
(DAD) detector, a HP 1100 MSD API-electrospray (Agilent Technologies) detector and a Luna C18
column 250 × 4.60 mm. The NMR spectra were recorded using a 400 MHz nuclear magnetic resonance
spectrometer Advance III.
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3.2. Experimental Results on Caco-2 cells
3.2.1. Cytotoxicity on Caco-2 cells
The cytotoxic effects of PPE on Caco-2 cells are presented in Figure 2. No cytotoxic effects were
observed in Caco-2 cells treated for 24 h with PPE at any concentrations tested 1.0, 2.5, 5.0, 10 and
25 µg/mL (p > 0.05).Nutrients 2019, 11, Firstpage-Lastpage FOR PEER REVIEW  7 of 16 
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Figure 2. Effect of exposure to PPE on Caco-2 cell viability, p ach data point repr sents n = 3;
data presented as mean ± st dard error. No significant differences were obs rved with PPE exposure
compared to the control (p > 0.05).
3.2.2. CXCL8 once tra ions in Caco-2 cell Super ts
The effects of the treatment of Caco-2 cells ith T F alone (positive control) or in combination
with either Dexamethasone (negative control) or increasing concentrations of PPE (1.0 µg/mL to
25 µg/mL) on CXCL8 secretion over 24 h is presented in Figure 3A. TNF challenged Caco-2 cells
treated with Dexamethasone had a 57% reduction in CXCL8 production compared to the positive
control (p < 0.001). The TNF challenged Caco-2 cells treated with 2.5, 5.0, 10 and 25 µg/mL of PPE
compared to the positive control cells had a reduction of 28% (p < 0.001), 35% (p < 0.001), 43% (p < 0.001)
and 40% (p < 0.001), respectively. There were no differences observed with treatment with 1.0 µg/mL
PPE (p > 0.05).
3.3. Experimental Results on Ex-Vivo Porcine Colonic Tissue Explants
3.3.1. CXCL8 Concentrations in the Supernatant
The anti-inflammatory effects of PPE (1.0 µg/mL to 25 µg/mL) on freshly excised ex vivo
colonic tissues co-stimulated with LPS are presented in Figure 3B. The CXCL8 concentrations in the
supernatants decreased with 5.0 and 25 µg/mL of PPE, with a 59.3% (p < 0.01) and 54.5% (p < 0.01)
reduction compared to the control, respectively. There were no differences observed with the other
PPE concentrations tested (p > 0.05).
3.3.2. Effect of LPS on Cytokine Expression in Porcine Colonic Tissues
The effect of LPS challenge on the expression of a selected panel of cytokine genes from the
ex vivo colonic tissues are summarized in Figure 4. The expression of IL17A and IL10 were not
affected by the LPS challenge. Compared to the untreated control, the LPS challenge increased the
expression of pro-inflammatory cytokines IL1A, IL1B, IL6, CXCL8, IFNG and TNF by 95.1% (p < 0.001),
84.7% (p < 0.001), 88.3% (p < 0.001), 88.3% (p < 0.001) and 84.2% (p < 0.01), respectively. In contrast,
the expression of TGFB1 was down-regulated (p < 0.01) compared to the untreated control.
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Figure 4. Differences in the expression of a selecte anel of cytokine genes between unchallenged
and lipopolysaccharide (LPS) challenged ex vivo colonic tissues. The red dots represent significant
upregulated genes (p < 0.05), the blue dot represents a significant downregulated gene (p < 0.05) and
the black dots represent genes not affected by LPS (p > 0.05).
3.3.3. Effect of PPE on Cytokine Expression in LPS Challenged Porcine Colonic Tissues
The effect of increasing concentrations of PPE on LPS challenged porcine colonic tissue explants
is presented in Figure 5. There were no ifferences observed in the expression of IL10, IL17A and
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IFNG between control and PPE treated tissues (Figure 5B). The co-treatment of LPS challenged porcine
tissues with 5.0 µg/mL of PPE was associated with the highest reduction of IL1A by 54.3% (p < 0.05),
IL6 by 70.6% (p < 0.01) and CXCL8 by 62.2% (p < 0.05) compared to the challenged control (Figure 5A).
Similarly, co-treatment of LPS challenged tissue with 2.5 µg/mL of PPE was associated with a 67.9%
(p < 0.05) reduction of IL6 (Figure 5A).
A heat map representing the correlations (R2) of a selected panel of cytokines in ex vivo porcine
colonic tissues post LPS challenge and co-treatment with PPE is presented in Figure 6. The expression
of cytokine IL1A is positively correlated to IL1B and TNF (p < 0.05). Similarly, the expression of CXCL8
is positively correlated to IL6 expression (p < 0.001).Nutrients 2019, 11, Firstpage-Lastpage FOR PEER REVIEW  10 of 16 
 
Figure 5. Effect of PPE co-treatment on relative quantity (RQ) of a selected panel of porcine cytokine 
genes in porcine colonic tissue explants stimulated by LPS, 3 h post-incubation. (A) Positively 
correlated genes. (B) Non correlated genes. In both panels, data point “Control” represents porcine 
colonic tissues stimulated with LPS. After challenge with LPS and co-treatment with PPE, total RNA 
was extracted, cDNA synthesised and QPCR performed to quantify the relative expression of the 
selected panel of genes. RQ values were compared to LPS challenged control. Each data point 
indicates mean ± standard error of 6 independent experiments. * p < 0.05 and ** p < 0.01 in comparison 
to control, n = 6. 
Figure 5. Effect of PPE co-treatment on relative quantity (RQ) of a selected panel of porcine cytokine
genes in porcine colonic tissue explants stimulated by LPS, 3 h post-incubation. (A) Positively correlated
genes. (B) Non correlated genes. In both panels, data point “Control” represents porcine colonic tissues
stimulated with LPS. After challenge with LPS and co-treatment with PPE, total RNA was extracted,
cDNA ynthesised and QPC performed to quantify the relative expressi n of the selected panel
of genes. RQ values were compared to LPS challenged control. Each data point indic tes mean ±
standard error of 6 independent experiments. * p < 0.05 and ** p < 0.01 in comparison to control, n = 6.
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4. Discussion
The “circular econo y” is an econo ic strategy that encourages the reuse and valorisation of
waste using environmentally frie l r fl s [16]. Hence the extraction of bioactive compounds
from the waste products of the pomegran te juice industry, using water as solvent, respects the main
princ ples of “The Green Ext action of Natural Prod cts” [45,46]. In this study, the anti-inflammatory
properties of PPE w re evaluated both in an in vi ro C co-2 cell model and in an ex vivo porcine
colonic explant model. Of significance was the fact that none of the tes ed concentrations of PPE
exhibited any cytotoxicity effects. Further investigations indicated that the higher concentrations of
PPE exhibited strong anti-inflammatory effects in both in vivo and ex vivo models by suppressing
CXCL8 concentrations in cell and tissue supernatants, respectively. The 5.0 µg/mL concentration of
PPE provided the most consistent results across all measures as it was also associated with the highest
suppression of pro-inflammatory cytokine (IL1A, IL6 and CXCL8) expression in the ex vivo model.
These data highlight the anti-inflammatory properties of pomegranate peel and support further
in vivo studies on inflammatory conditions of the gastrointestinal tract and other organs of the
body. Indeed, numerous therapeutic properties of pomegranate extracts have been characterised
in a variety of in vitro, animal and clinical trials [47]. Recent studies have investigated the possible
role of micronutrients and bioactive compounds found in plant-derived foods such as vitamins,
and polyphenols in the management of IBD [35,36]. In clinical trials, curcumin and beverages rich in
polyphenols as green tea have effectively reduced the symptoms in IBD patients [35]. To the best of
our knowledge, punicalagins have not been included so far in these studies even if they are recognized
as the most therapeutically beneficial pomegranate constituents [47].
Numerous studies have demonstrated that during both chr nic unresolved and acute i flammation
of the gastro ntestinal tr c , there is an imbalanc in the infl mmatory cytokine profile [33]. The inflamed
intestinal immun sys m has elevat d levels of pro-inflammatory cytokines, while the resolving
anti-inflammatory cytokines are under-represented, often resulti g in chronic inflammati and
diseases such as IBD [32,34]. Both acute and chr nic gut inflammatory co ditions a e haracterised
by up-regulation of pro-inflammatory cytokines, especially TNF and CXCL8. While TNF is considered to
be one of the main pro-inflammatory mediators [48,49], CXCL8 (produced by immune cells macrophages,
endothelial cells and epithelial cells) possess chemotactic activities targeting T lymphocytes, basophils
and neutrophils [50]. Interestingly, in the current study, when Caco-2 cells were stimulated with TNF
and co-treated with an increasing range of concentrations of PPE, a reduction in secretion of CXCL8
was observed.
Our current findings are in accordance to a previous study by Hollebeeck et al. [51] that observed
the anti-inflammatory properties of a polyphenol component of pomegranate husk, punicalagin,
in Caco-2 cells. While this study also used Caco-2 cells, they induced inflammation using a cocktail
of IL1B, TNF, IFNG and LPS after treating the cells with the pomegranate husk extracts for 1 h.
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Interestingly, the observations are similar in both studies, a reduction in pro-inflammatory cytokines
(mRNA and proteins) are recorded, alluding the potential of PPE as anti-inflammatory agent.
While the single layer of Caco-2 cells is suited for initial screening of bioactive compounds, it is
also a limiting factor in understanding the mechanisms involved in vivo [40]. The ex vivo colonic
models, reflecting the in vivo complexity of colonic tissue provides a greater insight compared to the
Caco-2 cell in vitro model [52]. Several previous studies have been based on the concept that pigs are
good models for human research and hence have used ex vivo porcine colonic explants to investigate
the anti-inflammatory effects of seaweed extracts [38] and milk hydrolysates [40,53]. Furthermore,
LPS, a bacterial endotoxin, is extensively used to mimic a microbial challenge. Bacterial LPS stimulates
the TLR4/MD-2 complex and exerts its effects by stimulating pro-inflammatory cytokines in the tissue
explants [54].
In this current study, LPS treatment of the porcine colonic tissues resulted in a significant increase
in the expression of a panel of pro-inflammatory cytokines indicating a successful pro-inflammatory
response against the LPS stimulus. Further to this, the anti-inflammatory properties of PPE in response
to the external LPS stimuli was validated in this ex vivo system. While the stimulation of porcine colonic
explants with LPS resulted in an up-regulation of both IL1A and IL1B, the co-treatment with 5.0 µg/mL
concentration of PPE was associated with a reduction in IL1A expression only. The pro-inflammatory
cytokine IL1A is produced by various cell types including monocytes/macrophages, neutrophils, and
endothelial cells, which mediate immune and inflammatory responses and is associated to formation
of inflammatory lesions in IBD patients [34]. This is in accordance with previous studies where
suppression of IL1A expression was observed in LPS stimulated porcine colonic tissue co-treated with
milk hydrolysate [39,53].
The pro-inflammatory cytokine IL6 plays a major role in inflammation, infection and cancer [55].
In healthy humans, the normal physiological concentrations of IL6 in serum are low; therefore,
elevated IL6 concentrations in the serum indicate systemic inflammation or infection. Elevated IL6
in both the serum and mucosal biopsies is an indicator of IBD [56]. In this current study, the LPS
challenge increased IL6 expression in colonic explants. Interestingly, co-treatment of LPS challenged
colonic explants simultaneously with 2.5 µg/mL and 5.0 µg/mL of PPE resulted in suppression of
IL6 expression.
Similar to IL6, elevated expression of the pro-inflammatory cytokine CXCL8 is observed in
mucosal diseases [34]. CXCL8 is a powerful neutrophil chemoattractant and activator, produced by
macrophages, epithelial cells, and fibroblasts in the intestinal mucosa [57]. The strong association
observed in several studies between concentrations of CXCL8 and intestinal inflammation has
highlighted this cytokine as an important clinical indicator of inflammation [58]. The decrease in CXCL8
concentrations observed in this study in response to PPE, both in supernatant of tissues stimulated
with LPS and in the LPS challenged colonic explants, highlight its potential as an anti-inflammatory
agent capable of lowering CXCL8 concentrations and even resolving inflammation in vivo. In addition,
this study confirms the anti-inflammatory effects evidenced by the reduction of both CXCL8 protein
and suppression of CXCL8 gene expression.
The suppression of IL6 and CXCL8 expression by PPE indicates that its anti-inflammatory potential
is most likely mediated through the suppression of the nuclear factor kappa B (NF-κβ) pathway. In fact,
a correlation analysis indicated that the expression of pro-inflammatory cytokines IL1A, IL1B, IL6,
CXCL8 and TNF were positively correlated with each other. The NF-κβ pathway plays a central role
in the inflammatory response, specifically by regulating the expression of cytokines involved in the
inflammation [59,60]. While polyphenols are known to suppress inflammatory responses by supressing
NF-κβ and mitogen-activated protein kinase (MAPK) signalling pathways [61], the underlying
mechanism of action of these compounds are still not well understood. In our previous study, using a
bovine mammary cell model [43], we observed anti-inflammatory activity by the same PPE used in
the current study. We suggested that the observed anti-inflammatory activity of PPE could be related
to a bioactive hydrolysable tannin, the punicalagin, that was present in high amounts (88.8%) in our
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extract in form of α and β isomers [43]. Additionally, in a previous study [62], punicalagin acted on
NF-κβ pathway as a suppressor of the phosphorylation of IκBα and p65, thus inhibiting the activation
of LPS induced NF-κβ. Hence, we propose that the anti-inflammatory activity of PPE observed in this
study in both in vitro and ex vivo models is highly associated to punicalagins present in PPE.
This study also gives an insight into the use of an increasing concentrations of PPE in both
in vitro and ex vivo models to optimise the best concentrations that can be used in further experiments.
While none of the concentrations used in this study elicits any cytotoxic effect in the in vitro model,
in the ex vivo model we observed a dose response, especially in the expression of cytokines IL1A,
IL6 and CXCL8. The 5.0 µg/mL concentration of PPE was associated with the highest reduction
in expression of these pro-inflammatory cytokines whereas with concentrations above 5.0 µg/mL
this anti-inflammatory effect is lost. A similar loss of bioactivity was observed in a previous study
using pistachio polyphenol extracts on LPS stimulated monocyte/macrophage cell-line J774-A1; while
0.1 mg/mL supressed IkB-α secretion, 0.5 mg/mL increased IkB-α secretion [63].
Therefore, dose response studies such as the current study are of high importance to evaluate
optimal doses to obtain bioactivities of potential food ingredients.
5. Conclusions
This study highlights the anti-inflammatory potential of a water extract of pomegranate peel
(PPE). PPE reduced the secretion of the pro-inflammatory cytokine CXCL8 in TNF stimulated Caco-2
cells. In addition, PPE reduced CXCL8 secretion as well as suppressing the gene expression of
pro-inflammatory cytokines (IL1A, IL6 and CXCL8) from LPS challenged colonic tissues. These results
suggest that PPE has the potential to be used as a functional food ingredient with applications in
the maintenance of gastrointestinal tract homeostasis. While the data presented in this study have
been generated in in vitro and ex vivo environments, they highlight the potential value of further
studies exploring the prevention of inflammatory conditions of the gastrointestinal tract, such as IBD,
with pomegranate extracts rich in punicalagins.
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